Abstract: The present disclosure provides an elastomeric material for the delivery of an ophthalmic agent to the eye of a subject and methods of using such material.

Abstract: The present disclosure provides an elastomeric material for the delivery of an ophthalmic agent to the eye of a subject and methods of using such material.

Abstract: The present invention relates generally to ophthamological drugs. More specifically, the invention relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to drugs modified (derivatized) in accordance with the instant method and to the use of same in treating conditions associated with elevated intraocular pressure, particularly, glaucoma.

Abstract: The present invention relates, in general, to glaucoma and, in particular, to a method of preventing or treating glaucoma using statins.

Abstract: The present invention relates generally to ophthamological drugs. More specifically, the invention relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to drugs modified (derivatized) in accordance with the instant method and to the use of same in treating conditions associated with elevated intraocular pressure, particularly, glaucoma.

Abstract: The present invention relates, in general, to methods of treating disorders of the eye, and, in particular, to methods of preventing or treating elevated eye pressure and glaucoma. The invention further relates to compounds and compositions suitable for use in such methods.

Abstract: The present invention relates, in general, to methods of treating disorders of the eye, and, in particular, to methods of preventing or treating elevated eye pressure and glaucoma. The invention further relates to compounds and compositions suitable for use in such methods.

Abstract: The present invention relates, in general, to methods of treating disorders of the eye, and, in particular, to methods of preventing or treating elevated eye pressure and glaucoma. The invention further relates to compounds and compositions suitable for use in such methods.

Abstract: A dispensing cap including a rotary valve communicating with an external open-ended dispensing tube portion, the valve being configured to communicate, in a venting position, with a venting pathway and to communicate, in a dispensing position, with an internal dispensing tube portion, wherein the valve is configured to pass from a closed position through a venting position to a dispensing position.

Abstract: A method of increasing aqueous humor outflow in the eye of a human patient to treat glaucoma, the method comprising topically administering to the eye an outflow-increasing amount of an analog of ethacrynic acid having a margin of safety of at least 2.0 and having the formula ##STR1## wherein each X.sub.1 and X.sub.2, independently, is a halogen, H, or CH.sub.3, or X.sub.1 and X.sub.2 together form a substituted or unsubstituted aromatic ring; X.sub.3 is an organic group; and X.sub.4 is OH or an organic group; provided that where X.sub.1 and X.sub.2 are Cl and X.sub.4 is OH, X.sub.3 cannot be 2-methylene-1-oxobutyl; or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates, in general, to methods of treating disorders of the eye, and, in particular, to methods of preventing or treating elevated eye pressure and glaucoma by administering to a patient in need thereof a non-sulfhydryl reactive derivative of phenoxyacetic acid (eg indacrinone or ticrynafen) that increases aqueous humor outflow. The invention further relates to compounds and compositions suitable for use in such methods.

Abstract: This invention features a bottle for dispensing liquids to an eye. The bottle preferably comprises sterile liquid, has a tube extending into and out of the bottle, with the outer part of this tube being flexible, and lying at an acute angle to the axis of the bottle.

Abstract: This invention is directed to improved treatment for glaucoma. It involves delivering to the eye molecules which increase the outflow of aqueous humor, in conjunction with masking agents. The masking agents reduce the side effects of the therapeutically active molecules by masking the sulfhydryl reactive groups on the molecules. The masking agents can be delivered separately from the molecules, or as adducts of the molecules.

Abstract: This invention features a bottle for dispensing liquids to an eye. The bottle preferably comprises sterile liquid, has tube portions extending into and out of the bottle, with the outer portion of this tube being flexible, and lying at an acute angle to the axis of the bottle.

Abstract: A method of increasing aqueous humor outflow in the eye of a human patient including topically administering to the eye an outflow increasing amount of a compound characterized in that it contains one or more groups capable of reacting with sulfhydryl groups in the trabecular meshwork of the eye, and it has a margin of safety of at least 2.0.